Cargando…
Isolated functional tricuspid regurgitation: how to define patients at risk for event?
AIMS: Functional tricuspid regurgitation (TR) is a turning point in cardiac diseases. Symptoms typically appear late. The optimal timing for proposing a valve repair remains a challenge. We sought to analyse the characteristics of right heart remodelling in patients with significant functional TR to...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10192508/ https://www.ncbi.nlm.nih.gov/pubmed/36811285 http://dx.doi.org/10.1002/ehf2.14189 |
_version_ | 1785043637246099456 |
---|---|
author | L'Official, Guillaume Vely, Mathilde Kosmala, Wojciech Galli, Elena Guerin, Anne Chen, Elisabeth Sportouch, Catherine Dreyfus, Julien Oger, Emmanuel Donal, Erwan |
author_facet | L'Official, Guillaume Vely, Mathilde Kosmala, Wojciech Galli, Elena Guerin, Anne Chen, Elisabeth Sportouch, Catherine Dreyfus, Julien Oger, Emmanuel Donal, Erwan |
author_sort | L'Official, Guillaume |
collection | PubMed |
description | AIMS: Functional tricuspid regurgitation (TR) is a turning point in cardiac diseases. Symptoms typically appear late. The optimal timing for proposing a valve repair remains a challenge. We sought to analyse the characteristics of right heart remodelling in patients with significant functional TR to identify the parameters that could be used in a simple prognostic model predicting clinical events. METHODS AND RESULTS: We designed a prospective observational French multicentre study including 160 patients with significant functional TR (effective regurgitant orifice area > 30 mm(2)) and left ventricular ejection fraction > 40%. Clinical, echocardiographic, and electrocardiogram data were collected at baseline and at the 1 and 2 year follow‐up. The primary outcome was all‐cause death or hospitalization for heart failure. At 2 years, 56 patients (35%) achieved the primary outcome. The subset with events showed more advanced right heart remodelling at baseline, but similar TR severity. Right atrial volume index (RAVI) and the tricuspid annular plane systolic excursion to systolic pulmonary arterial pressure (TAPSE/sPAP) ratio, reflecting right ventricular–pulmonary arterial coupling, were 73 mL/m(2) and 0.40 vs. 64.7 mL/m(2) and 0.50 in the event vs. event‐free groups, respectively (both P < 0.05). None among all the clinical and imaging parameters tested had a significant group × time interaction. The multivariable analysis leads to a model including TAPSE/sPAP ratio > 0.4 (odds ratio = 0.41, 95% confidence limit 0.2 to 0.82) and RAVI > 60 mL/m(2) (odds ratio = 2.13, 95% confidence limit 0.96 to 4.75), providing a clinically valid prognostic evaluation. CONCLUSIONS: RAVI and TAPSE/sPAP are relevant for predicting the risk for event at 2 year follow‐up in patients with an isolated functional TR. |
format | Online Article Text |
id | pubmed-10192508 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-101925082023-05-19 Isolated functional tricuspid regurgitation: how to define patients at risk for event? L'Official, Guillaume Vely, Mathilde Kosmala, Wojciech Galli, Elena Guerin, Anne Chen, Elisabeth Sportouch, Catherine Dreyfus, Julien Oger, Emmanuel Donal, Erwan ESC Heart Fail Original Articles AIMS: Functional tricuspid regurgitation (TR) is a turning point in cardiac diseases. Symptoms typically appear late. The optimal timing for proposing a valve repair remains a challenge. We sought to analyse the characteristics of right heart remodelling in patients with significant functional TR to identify the parameters that could be used in a simple prognostic model predicting clinical events. METHODS AND RESULTS: We designed a prospective observational French multicentre study including 160 patients with significant functional TR (effective regurgitant orifice area > 30 mm(2)) and left ventricular ejection fraction > 40%. Clinical, echocardiographic, and electrocardiogram data were collected at baseline and at the 1 and 2 year follow‐up. The primary outcome was all‐cause death or hospitalization for heart failure. At 2 years, 56 patients (35%) achieved the primary outcome. The subset with events showed more advanced right heart remodelling at baseline, but similar TR severity. Right atrial volume index (RAVI) and the tricuspid annular plane systolic excursion to systolic pulmonary arterial pressure (TAPSE/sPAP) ratio, reflecting right ventricular–pulmonary arterial coupling, were 73 mL/m(2) and 0.40 vs. 64.7 mL/m(2) and 0.50 in the event vs. event‐free groups, respectively (both P < 0.05). None among all the clinical and imaging parameters tested had a significant group × time interaction. The multivariable analysis leads to a model including TAPSE/sPAP ratio > 0.4 (odds ratio = 0.41, 95% confidence limit 0.2 to 0.82) and RAVI > 60 mL/m(2) (odds ratio = 2.13, 95% confidence limit 0.96 to 4.75), providing a clinically valid prognostic evaluation. CONCLUSIONS: RAVI and TAPSE/sPAP are relevant for predicting the risk for event at 2 year follow‐up in patients with an isolated functional TR. John Wiley and Sons Inc. 2023-02-21 /pmc/articles/PMC10192508/ /pubmed/36811285 http://dx.doi.org/10.1002/ehf2.14189 Text en © 2022 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Articles L'Official, Guillaume Vely, Mathilde Kosmala, Wojciech Galli, Elena Guerin, Anne Chen, Elisabeth Sportouch, Catherine Dreyfus, Julien Oger, Emmanuel Donal, Erwan Isolated functional tricuspid regurgitation: how to define patients at risk for event? |
title | Isolated functional tricuspid regurgitation: how to define patients at risk for event? |
title_full | Isolated functional tricuspid regurgitation: how to define patients at risk for event? |
title_fullStr | Isolated functional tricuspid regurgitation: how to define patients at risk for event? |
title_full_unstemmed | Isolated functional tricuspid regurgitation: how to define patients at risk for event? |
title_short | Isolated functional tricuspid regurgitation: how to define patients at risk for event? |
title_sort | isolated functional tricuspid regurgitation: how to define patients at risk for event? |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10192508/ https://www.ncbi.nlm.nih.gov/pubmed/36811285 http://dx.doi.org/10.1002/ehf2.14189 |
work_keys_str_mv | AT lofficialguillaume isolatedfunctionaltricuspidregurgitationhowtodefinepatientsatriskforevent AT velymathilde isolatedfunctionaltricuspidregurgitationhowtodefinepatientsatriskforevent AT kosmalawojciech isolatedfunctionaltricuspidregurgitationhowtodefinepatientsatriskforevent AT gallielena isolatedfunctionaltricuspidregurgitationhowtodefinepatientsatriskforevent AT guerinanne isolatedfunctionaltricuspidregurgitationhowtodefinepatientsatriskforevent AT chenelisabeth isolatedfunctionaltricuspidregurgitationhowtodefinepatientsatriskforevent AT sportouchcatherine isolatedfunctionaltricuspidregurgitationhowtodefinepatientsatriskforevent AT dreyfusjulien isolatedfunctionaltricuspidregurgitationhowtodefinepatientsatriskforevent AT ogeremmanuel isolatedfunctionaltricuspidregurgitationhowtodefinepatientsatriskforevent AT donalerwan isolatedfunctionaltricuspidregurgitationhowtodefinepatientsatriskforevent |